Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCrewe Advisors LLC
Latest Disclosed Ownership1,335 shares
Latest Disclosed Value $ 469,720
Crewe Advisors LLC reports 2.30% increase in ownership of AMGN / Amgen Inc.

On May 7, 2026 - Crewe Advisors LLC filed a 13F-HR form disclosing ownership of 1,335 shares of Amgen Inc. (MX:AMGN) valued at $469,720 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 1,305 shares of Amgen Inc.. This represents a change in shares of 2.30% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F AMGEN COM 031162100 1,335 30 2.30 470 9.84 0.0401
2026-01-16 2025-12-31 13F AMGEN COM 031162100 1,305 10 0.77 427 16.99 0.0378
2025-11-13 2025-09-30 13F AMGEN COM 031162100 1,295 1 0.08 365 1.11 0.0349
2025-07-30 2025-06-30 13F AMGEN COM 031162100 1,294 17 1.33 361 -9.07 0.0511
2025-04-23 2025-03-31 13F AMGEN COM 031162100 1,277 -6 -0.47 398 18.86 0.0559
2025-01-27 2024-12-31 13F AMGEN COM 031162100 1,283 -169 -11.64 334 -28.48 0.0461
2024-11-12 2024-09-30 13F AMGEN COM 031162100 1,452 6 0.41 468 3.55 0.0543
2024-07-29 2024-06-30 13F AMGEN COM 031162100 1,446 -39 -2.63 452 6.87 0.0506
2024-05-14 2024-03-31 13F AMGEN COM 031162100 1,485 1,485 422 0.0492
2023-11-09 2023-09-30 13F AMGEN COM 031162100 0 -1,279 -100.00 0 -100.00
2023-07-28 2023-06-30 13F AMGEN COM 031162100 1,279 -16 -1.24 284 -9.58 0.0399
2023-05-12 2023-03-31 13F AMGEN COM 031162100 1,295 -45 -3.36 313 -10.83 0.0457
2023-02-08 2022-12-31 13F AMGEN COM 031162100 1,340 698 108.72 352 142.07 0.0558
2022-11-14 2022-09-30 13F AMGEN COM 031162100 642 -53 -7.63 145 -14.20 0.0262
2022-08-02 2022-06-30 13F AMGEN COM 031162100 695 146 26.59 169 27.07 0.0373
2022-04-27 2022-03-31 13F AMGEN COM 031162100 549 329 149.55 133 171.43 0.0260
2022-02-10 2021-12-31 13F AMGEN COM 031162100 220 0 0.00 49 4.26 0.0100
2021-10-29 2021-09-30 13F AMGEN COM 031162100 220 0 0.00 47 -12.96 0.0111
2021-08-11 2021-06-30 13F AMGEN COM 031162100 220 0 0.00 54 -1.82 0.0134
2021-04-21 2021-03-31 13F AMGEN COM 031162100 220 0 0.00 55 7.84 0.0136
2021-01-27 2020-12-31 13F AMGEN COM 031162100 220 -74 -25.17 51 -32.00 0.0204
2020-10-13 2020-09-30 13F AMGEN COM 031162100 294 74 33.64 75 44.23 0.0352
2020-07-24 2020-06-30 13F AMGEN COM 031162100 220 0 0.00 52 15.56 0.0254
2020-05-07 2020-03-31 13F AMGEN COM 031162100 220 0 0.00 45 -15.09 0.0269
2020-02-05 2019-12-31 13F AMGEN COM 031162100 220 0 0.00 53 23.26 0.0232
2019-11-05 2019-09-30 13F AMGEN COM 031162100 220 -24 -9.84 43 -4.44 0.0198
2019-08-09 2019-06-30 13F AMGEN COM 031162100 244 22 9.91 45 7.14 0.0146
2019-05-10 2019-03-31 13F AMGEN COM 031162100 222 2 0.91 42 -2.33 0.0132
2019-02-05 2018-12-31 13F AMGEN COM 031162100 220 0 0.00 43 -6.52 0.0136
2018-11-13 2018-09-30 13F AMGEN COM 031162100 220 0 0.00 46 12.20 0.0389
2018-08-07 2018-06-30 13F AMGEN COM 031162100 220 -138 -38.55 41 -32.79 0.0381
2018-05-07 2018-03-31 13F AMGEN COM 031162100 358 53 17.38 61 15.09 0.0598
2018-02-09 2017-12-31 13F AMGEN COM 031162100 305 305 53 0.0519
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.